Noxsano is a pioneering company in the veterinary wound care market, offering innovative products designed to accelerate the healing process for both acute and chronic wounds in animals. The company's core offerings include nitric oxide delivering wound pads and gels, which are clinically proven to promote faster healing, reduce the frequency of dressing changes, and lower overall treatment costs. Noxsano's flagship product, Restore Wound Gel, is particularly effective for large wounds, cavity wounds, complex geometries, or wounds in high-motion areas, making it versatile for various veterinary applications.

Noxsano serves veterinary professionals who are looking for effective and efficient wound care solutions for their animal patients, ranging from equines to canines and more. The company operates in the veterinary healthcare market, focusing on providing high-quality, clinically proven products that improve treatment outcomes.

Noxsano's business model revolves around the sale of its wound care products to veterinary clinics and hospitals. Revenue is generated through direct sales and potentially through partnerships with veterinary supply distributors.

Founded by Alan, an innovator with 26 years of experience at Procter & Gamble in energy-activated chemical technologies, and Arti, a board-certified MD with extensive experience in medical leadership and wound care innovation, Noxsano combines deep industry knowledge with cutting-edge technology to deliver superior wound care solutions.

Keywords: veterinary wound care, nitric oxide, faster healing, wound pads, wound gels, acute wounds, chronic wounds, veterinary professionals, animal health, clinical innovation.